03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On September 24, 2019, the U.S. Department of the Treasury (“Treasury”) published two proposed rul...
Read More >
On January 21, 2020, the governor of New Jersey signed into law arguably the most stringent provisio...
Read More >
One effect of the COVID-19 pandemic is the renewed need for transportation providers to consider str...
Read More >
In a welcomed attempt to align their approaches, the antitrust enforcers of the European Competition...
Read More >
Summary - On September 18, 2019, Governor Newsom signed California Assembly Bill 5 (AB 5) into law ...
Read More >
On July 1, 2019, Chapter 558, Florida Statutes, will be amended to add section 558.004(1)(d), which ...
Read More >